Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Annual Financial Report

26th Mar 2025 10:30

RNS Number : 3043C
Rentokil Initial PLC
26 March 2025
 

Rentokil Initial plc (the 'Company')

 

Annual Report and Annual General Meeting

 

In compliance with Listing Rule 6.4.1, the Company announces that the following documents, in unedited full text, have today been filed with the Financial Conduct Authority and are available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

 

· Annual Report and Financial Statements for the year ended 31 December 2024 (the Annual Report 2024);

· Notice of 2025 Annual General Meeting (AGM); and

· Proxy Form for the 2025 AGM.

 

The documents will be posted today, and the Annual Report 2024 and the Notice of 2025 AGM have been published on the Company's website at rentokil-initial.com/investors.

 

The 2025 AGM will be held at, and broadcast from, the Company's offices at Compass House, Manor Royal, Crawley, RH10 9PY on Wednesday 7 May 2025 at 2:00pm. Full details of how to participate in the meeting can be found in the Notice of Meeting.

 

In addition, the Company has filed its Annual Report on Form 20-F with the US Securities and Exchange Commission (SEC). The document is available for viewing on the SEC website at www.sec.gov and also on the Company's website at rentokil-initial.com/investors. If you would like to receive a hard copy of the Annual Report 2024 please contact the Company Secretariat team by email at [email protected] or on +44 (0)1293 858000.

 

 

Additional note

Following the printing of the Annual Report, the Carbon Disclosure Project informed the Company about an error in its scoring infrastructure. Following the recalculation, Rentokil Initial's Climate rating was recalculated to C, rather than D.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSEFSUMEISEED

Related Shares:

Rentokil Initial
FTSE 100 Latest
Value8,634.80
Change0.00